{"title":"医用大麻与新冠肺炎：注。","authors":"Beuy Joob, Viroj Wiwanitkit","doi":"10.4103/ayu.ayu_276_22","DOIUrl":null,"url":null,"abstract":"Medical Marijuana (Cannabis sativa L.) is presently widely used due to legalization in many countries.[1] An important consideration is the effect of Marijuana on other medical disorders. Here, the authors focus special interest on COVID‐19, the new emerging coronavirus infection. A basic question is whether there is any interrelationship between the pathological pathway of coronavirus infection and the pharmacological pathway of Marijuana.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/61/AYU-43-32.PMC10405885.pdf","citationCount":"0","resultStr":"{\"title\":\"Medical <i>Marijuana</i> (<i>Cannabis sativa</i> L.) and COVID-19: A note.\",\"authors\":\"Beuy Joob, Viroj Wiwanitkit\",\"doi\":\"10.4103/ayu.ayu_276_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Medical Marijuana (Cannabis sativa L.) is presently widely used due to legalization in many countries.[1] An important consideration is the effect of Marijuana on other medical disorders. Here, the authors focus special interest on COVID‐19, the new emerging coronavirus infection. A basic question is whether there is any interrelationship between the pathological pathway of coronavirus infection and the pharmacological pathway of Marijuana.\",\"PeriodicalId\":8720,\"journal\":{\"name\":\"Ayu\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/61/AYU-43-32.PMC10405885.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ayu\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ayu.ayu_276_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.ayu_276_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Medical Marijuana (Cannabis sativa L.) and COVID-19: A note.
Medical Marijuana (Cannabis sativa L.) is presently widely used due to legalization in many countries.[1] An important consideration is the effect of Marijuana on other medical disorders. Here, the authors focus special interest on COVID‐19, the new emerging coronavirus infection. A basic question is whether there is any interrelationship between the pathological pathway of coronavirus infection and the pharmacological pathway of Marijuana.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
